With a significant positively correlation with serum hsCRP levels, AHR transcripts in PBMCs may represent as a novel mediator of the immune disturbance and meta-inflammation in obesity and T2D patients, independent of leptin, the previously-known key metabolic controller and immune modulator (36). This evidence concerns the gene LEP and type 2 diabetes mellitus.